Management of Differentiated Thyroid Cancer in the Presence of Resistance to Thyroid Hormone and TSH-Secreting Adenomas: A Report of Four Cases and Review of the Literature | Zendy

Uğur Ünlütürk | Zendy; Chutintorn Sriphrapradang | Zendy; Murat Faik Erdoğan | Zendy; Rıfat Emral | Zendy; Sibel Güldiken | Zendy; Samuel Refetoff | Zendy; Sevim Güllü | Zendy

Open Access

Management of Differentiated Thyroid Cancer in the Presence of Resistance to Thyroid Hormone and TSH-Secreting Adenomas: A Report of Four Cases and Review of the Literature

Author(s) -

Uğur Ünlütürk,

Chutintorn Sriphrapradang,

Murat Faik Erdoğan,

Rıfat Emral,

Sibel Güldiken,

Samuel Refetoff,

Sevim Güllü

Publication year - 2013

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-4142

Subject(s) - medicine , hormone , thyroid , thyroid stimulating hormone , thyroid cancer , endocrinology , cancer , etiology

An increased or normal serum TSH concentration, despite elevated thyroid hormone levels, is observed in resistance to thyroid hormone (RTH) and TSH-secreting adenomas (TSHomas). When coexistent with a differentiated thyroid cancer (DTC), maintenance of a suppression of TSH is challenging.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research